Darya Starosyla

Darya Starosyla

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2018 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
NMNataliia Melnichuk
Nataliia Melnichuk
VKVladimir Kashuba
Vladimir Kashuba
DSDarya Starosyla
Darya Starosyla
ZTZenoviy Tkachuk
Zenoviy Tkachuk
Rapid replication of the influenza A virus and lung tissue damage caused by exaggerated pro-inflammatory host immune responses lead to numerous deaths. Therefore, novel therapeutic agents that have anti-influenza activities and attenuate excessive pro-inflammatory responses that are induced by an influenza virus infection are needed. Oligoribonucleotides-d-mannitol (ORNs-d-M) complexes possess both antiviral and anti-inflammatory activities. The current research was aimed at studying the ORNs-d-M effects on expression of innate immune genes in mice lungs during an influenza virus infection. Expression of genes was determined by RT-qPCR and Western blot assays. In the present studies, we found that the ORNs-d-M reduced the influenza-induced up-expression of Toll-like receptors (TLRs) (tlr3, tlr7, tlr8), nuclear factor NF-kB (nfkbia, nfnb1), cytokines (ifnε, ifnk, ifna2, ifnb1, ifnγ, il6, il1b, il12a, tnf), chemokines (ccl3, ccl4, сcl5, cxcl9, cxcl10, cxcl11), interferon-stimulated genes (ISGs) (oas1a, oas2, oas3, mx1), and pro-oxidation (nos2, xdh) genes. The ORNs-d-M inhibited the mRNA overexpression of tlr3, tlr7, and tlr8 induced by the influenza virus, which suggests that they impair the upregulation of NF-kB, cytokines, chemokines, ISGs, and pro-oxidation genes induced by the influenza virus by inhibiting activation of the TLR-3, TLR-7, and TLR-8 signaling pathways. By impairing activation of the TLR-3, TLR-7, and TLR-8 signaling pathways, the ORNs-d-M can modulate the innate immune response to an influenza virus infection.

1 November 2017
Verified
Conference Paper
Open access
SZSvitlana D Zahorodnia
Svitlana D Zahorodnia
AGAnna Golovan
Anna Golovan
GBGalyna Baranova
Galyna Baranova
DSDarya Starosyla
Darya Starosyla
LZLiubov Zelena
Liubov Zelena
VAV. Atamanyuk
V. Atamanyuk
Epstein-Barr virus (EBV) belongs to the human herpes virus family that infects more than 90% of the population. EBV is associated with a number of lymphoproliferative and autoimmune diseases. Use of the drugs, which would not only inhibit the reproduction of the virus, but also would stimulate the elimination of tumor cells, is important for the treatment of virus-associated tumors. In the current research the antiviral effects of the herbal extracts Proteflazid and Neoflazid were studied on the models of latent, acute and chronic EBV infections in Raji and B95-8 lymphoblastoid cells. Neoflazid was more toxic towards Raji cells than Proteflazid: the CC50 indices were 8 µg/ml and 36 µg/ml respectively. Toxicities of these compounds in B95-8 cells were almost the same and their CC50 indices were close to 25 µg/ml. Both drugs showed high antiviral activity against EBV lytic infection in Raji cells and EC50 was 0.02 and 0.083 µg/ml for Proteflazid and Neoflazid, respectively, and selectivity indinces were 1800 and 96. They were less effective in B95-8 cells and even at a concentration of 10 µg/ml these compounds inhibited virus replication by only 10-19%. We checked the ability of Proteflazid to induce apoptosis and found that the drug stimulated the apoptotic cell death in latent and lytic EBV infections at cytotoxic concentrations (30 µg/ml). The non-toxic concentration (5 µg/ml) induced apoptosis more actively (by 10%) during EBV lytic infection in cells B95-8 than in the case of latent infection in Raji cells.